Breckenridge Pharmaceutical Inc

About

Breckenridge Pharmaceutical Inc, headquartered in Berlin, Connecticut, stands as a leading distributor of quality generic pharmaceuticals in the United States market. As the U.S. subsidiary of Towa Pharmaceutical of Osaka, Japan, the company leverages over 40 years of industry expertise since its founding in 1983 to deliver cost-effective pharmaceutical solutions nationwide. Breckenridge specializes in marketing and distributing an extensive portfolio of over 70 generic products across diverse dosage forms, including tablets, capsules, liquids, suspensions, ophthalmics, nasal sprays, powders, and injectable products. Their robust pipeline features more than 80 products in development, including 25 containing Paragraph IV patent challenges, plus innovative delivery systems such as inhalers, transdermal patches, and topical formulations. With 30 FDA-approved Abbreviated New Drug Applications in their portfolio, Breckenridge maintains rigorous quality standards throughout their comprehensive manufacturing and distribution network. The company operates through strategic partnerships with research and development centers nationwide and internationally, ensuring continuous innovation and reliable supply chains. Their turn-key pharmaceutical solutions encompass business development, regulatory operations, supply chain management, and sales and marketing support, providing customers with seamless service from product development through distribution while maintaining unwavering commitment to improving patient health outcomes.